Literature DB >> 1308556

Experimental Chagas' disease in dogs.

M de Lana1, E Chiari, W L Tafuri.   

Abstract

This paper describes the development of experimental Chagas' disease in 64 out-bred young dogs. Twenty-nine animals were inoculated with the Be-62 and 35 with Be-78 Trypanosoma cruzi strains. Twenty-six were infected with blood trypomastigotes by different inoculation routes and 38 with metacyclic trypomastigotes from the vector via the conjunctival route. Twenty of the 26 dogs infected with blood trypomastigotes were autopsied during the acute phase. Eleven died spontaneously and nine were sacrificed. Six remained alive until they died suddenly (two) or were autopsied. (four). Twelve of the 38 dogs infected with metacyclic trypomastigotes evolved naturally to the chronic phase and remained alive for 24-48 months. The parasitemia, clinical aspects and serology (IgM and IgG) as well as electrocardiogram, hemogram and heart anatomo-histopathologic patterns of acute and chronic cardiac forms of Chagas' disease as seen in human infections, were reproduced. The most important finding is the reproducibility of diffuse fibrosing chronic chagasic cardiopathy in all dogs infected with Be-78 T. cruzi strain autopsied between the 90th and 864th days of infection. Thus, the dog can be considered as a suitable experimental model to study Chagas' disease according to the requisites of the Word Health Organization (1984). Furthermore the animal is easily obtained and easy to handle and maintain in experimental laboratory conditions.

Entities:  

Mesh:

Year:  1992        PMID: 1308556     DOI: 10.1590/s0074-02761992000100011

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  22 in total

1.  Morphological and morphometric study of atrial specific granules and other secretory components in dogs experimentally infected with Trypanosoma cruzi.

Authors:  M V Caliari; M Lana; V H Leite; W L Tafuri
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

2.  In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; R Lira; G Visbal; J Bartrolí
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.

Authors:  Rodrigo Moreira da Silva; Líliam Teixeira Oliveira; Neila Márcia Silva Barcellos; Jacqueline de Souza; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

4.  Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.

Authors:  Lilian Melo; Ivo Santana Caldas; Maíra Araújo Azevedo; Karolina Ribeiro Gonçalves; Alvaro Fernando da Silva do Nascimento; Vivian Paulino Figueiredo; Lívia de Figueiredo Diniz; Wanderson Geraldo de Lima; Rosália Moraes Torres; Maria Terezinha Bahia; André Talvani
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

5.  Trypanosoma cruzi circulating in the southern region of the State of Mexico (Zumpahuacan) are pathogenic: a dog model.

Authors:  Alberto Barbabosa-Pliego; Hector M Díaz-Albiter; Laucel Ochoa-García; Esteban Aparicio-Burgos; Sandra M López-Heydeck; Valente Velásquez-Ordoñez; Raul C Fajardo-Muñoz; Sandra Díaz-González; Roberto Montes De Oca-Jimenez; Marco Barbosa-Mireles; Carmen Guzmán-Bracho; Jose G Estrada-Franco; Nisha Jain Garg; Juan C Vázquez-Chagoyán
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

6.  Evaluation of clinical and immunopathological features of different infective doses of Trypanosoma cruzi in dogs during the acute phase.

Authors:  Israel A Quijano-Hernández; Alejandro Castro-Barcena; Esteban Aparicio-Burgos; Marco A Barbosa-Mireles; Julio V Cruz-Chan; Juan C Vázquez-Chagoyán; Manuel E Bolio-González; Eric Dumonteil
Journal:  ScientificWorldJournal       Date:  2012-04-01

7.  Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model.

Authors:  Olivia Rodríguez-Morales; M Magdalena Pérez-Leyva; Martha A Ballinas-Verdugo; Silvia C Carrillo-Sánchez; J Luis Rosales-Encina; Ricardo Alejandre-Aguilar; Pedro A Reyes; Minerva Arce-Fonseca
Journal:  Vet Res       Date:  2012-11-13       Impact factor: 3.683

8.  Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.

Authors:  José E Aparicio-Burgos; Laucel Ochoa-García; José Antonio Zepeda-Escobar; Shivali Gupta; Monisha Dhiman; José Simón Martínez; Roberto Montes de Oca-Jiménez; Margarita Val Arreola; Alberto Barbabosa-Pliego; Juan C Vázquez-Chagoyán; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

9.  Unequivocal identification of subpopulations in putative multiclonal Trypanosoma cruzi strains by FACs single cell sorting and genotyping.

Authors:  Helder Magno Silva Valadares; Juliana Ramos Pimenta; Marcela Segatto; Vanja Maria Veloso; Mônica Lúcia Gomes; Egler Chiari; Kenneth John Gollob; Maria Terezinha Bahia; Marta de Lana; Glória Regina Franco; Carlos Renato Machado; Sérgio Danilo Junho Pena; Andréa Mara Macedo
Journal:  PLoS Negl Trop Dis       Date:  2012-07-10

10.  Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model.

Authors:  Olivia Rodríguez-Morales; Silvia C Carrillo-Sánchez; Humberto García-Mendoza; Alberto Aranda-Fraustro; Martha A Ballinas-Verdugo; Ricardo Alejandre-Aguilar; José Luis Rosales-Encina; Maite Vallejo; Minerva Arce-Fonseca
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.